Novo Nordisk A/S
Novo Nordisk A/S (XETRA: NOV) is trading at €33.40, about ₹3,638 at today's EUR/INR rate, as of 30 Sep 2026, 5:05 AM ET, down 1.04% today. Indian residents can buy Novo Nordisk from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€33.40
Today's high
€33.95
52 week low
€30.04
52 week high
€54.87
NOV opened at €33.93, closed previously at €33.75, and has traded between €30.04 and €54.87 over the past 52 weeks.
About
Novo Nordisk A/S, along with its affiliated companies, focuses on the discovery, production, and global sale of pharmaceutical goods. Its market presence extends across Europe, the Middle East, Africa, North America, and various Asian territories, including Mainland China, Hong Kong, and Taiwan. The company's activities are divided into two main categories: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division offers therapeutic solutions for conditions such as diabetes, obesity, cardiovascular health, and other developing medical areas. Meanwhile, the Rare Disease division provides treatments for unusual blood conditions, uncommon endocrine disorders, and hormone replacement therapies. Beyond its drug portfolio, Novo Nordisk also manufactures medical devices like insulin pens, growth hormone pens, and injection needles. Furthermore, it develops intelligent tools for diabetes management, including advanced smart insulin pens and the Dose Check application, designed to assist with insulin dosage guidance. The company holds a cooperative agreement with Aspen Pharmaceuticals for the manufacturing of insulin products. Novo Nordisk A/S was founded in 1923 and its corporate headquarters are located in Bagsvaerd, Denmark.
Key statistics
Avg. volume
207.11K
Market cap
€148.38B
P/E Ratio
9.52
Price-to-sales ratio
3.37
Enterprise value
DKK 1.57T
Free cash flow yield
4.03%
Debt-to-equity ratio
0.63
Return on equity
52.79%
ROIC
29.59%
Beta
0.35
Dividend yield
4.69%
Last dividend
€1.56
Financial overview
Revenue
DKK 308.39B
Earnings per share
DKK 23.01
Free cash flow
DKK 58.83B
Net profit margin
35.35%
Gross margin
80.65%
EBITDA
DKK 158.95B
Revenue growth
6.19%
How to buy Novo Nordisk from India
Indian residents can buy Novo Nordisk shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for Novo Nordisk and place an order
Find Novo Nordisk by name or by its ticker, NOV, and choose an order type. Novo Nordisk trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Novo Nordisk position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Novo Nordisk from India
Trading and taxes when buying Novo Nordisk from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Novo Nordisk’s current yield is 4.69%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Novo Nordisk stock?
Yes. Novo Nordisk (NOV) has been listed on XETRA since 2001, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Novo Nordisk share cost in rupees?
One Novo Nordisk share is €33.40 — about ₹3,638 at an EUR/INR rate of 108.91 on 29 Sep 2026. Both the Novo Nordisk price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Novo Nordisk from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Novo Nordisk shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Novo Nordisk price. Paasa issues a capital-gains statement for your return.
Does Novo Nordisk pay a dividend, and how is it taxed in India?
Yes. Novo Nordisk pays a dividend and the current yield is 4.69%; the last declared dividend was €1.56 per share, about ₹170.31. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Novo Nordisk from India?
XETRA trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Germany is on standard time. Orders can only execute during that window.
Is Novo Nordisk a Germany company, and does that change how it is taxed?
Novo Nordisk trades on XETRA in EUR, but the company is domiciled in Denmark. Novo Nordisk trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Novo Nordisk shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Novo Nordisk holding, its cost and its closing value.
How do I sell Novo Nordisk and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on Novo Nordisk?
Yes. Novo Nordisk is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.